Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYMedicina (Kaunas, Lithuania)

Lactobacillus rhamnosus Lysate for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial

9 affiliations
  1. 1Physiology Department, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine;
  2. 2Endocrinology Department, Bogomolets National Medical University, 01601 Kyiv, Ukraine; (Y.I.); (E.C.); (V.Y.)
  3. 3Center for Innovative Medical Technologies, National Academy of Sciences of Ukraine, 04053 Kyiv, Ukraine;
  4. 4Kyiv City Clinical Endocrinology Center, 01601 Kyiv, Ukraine;
  5. 5Educational and Scientific Centre “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, 01601 Kyiv, Ukraine;
  6. 6Department of Biochemistry and Pharmacology, Uzhhorod National University, 88000 Uzhhorod, Ukraine;
  7. 7Department of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine;
  8. 8KSE Health, Aging and Diseases Center, Kyiv School of Economics, 02000 Kyiv, Ukraine;
  9. 9MirImmunoPharm, 04111 Kyiv, Ukraine;

Related

  1. Lactobacillus rhamnosus ameliorates pulmonary dysfunction in a rat model of chronic obstructive pulmonary disease.
    Ruijing Yan, Jialu Zhang, Yinan Li +1
    AMB ExpressPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  2. GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
    Shi-ping Sun, Yan Fang, Li Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
    Michihiro Iwaki, Hiroshi Tobita, Yuya Seko +38
    eClinicalMedicinePeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  4. Effects of Whole “Navelina” Orange Consumption on Glucose Homeostasis and Fructosamine Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Controlled Trial
    Valentina De Nunzio, Davide Guido, Giuliano Pinto +8
    NutrientsPeer-reviewedCC BY 4.0NutritionCrossref
  5. Efficacy of Hongjing Qiwei Formula Combined with Tadalafil in the Treatment of Erectile Dysfunction Associated with Type 2 Diabetes Mellitus: A Double-Blind, Single-Dummy, Randomized Controlled Trial
    Hao Wang, Yongqing Zhao, Hongyuan Chang +4
    Diabetes, Metabolic Syndrome and ObesityPeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthPMC
BibTeX
@article{savytska2026lactobacillus,
  title = {{Lactobacillus rhamnosus Lysate for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial}},
  author = {Maryana Savytska and Yeva Ilkiv and Olena Baka and Elina Christian and Viktoriia Yerokhovych and Dmytro Kyriienko and Tetyana Falalyeyeva and Pavlo Petakh and Iryna Halabitska and Oleksandr Kamyshnyi and Liubov Sichel and Nazarii Kobyliak},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13706883},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Lactobacillus rhamnosus Lysate for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial
AU  - Maryana Savytska
AU  - Yeva Ilkiv
AU  - Olena Baka
AU  - Elina Christian
AU  - Viktoriia Yerokhovych
AU  - Dmytro Kyriienko
AU  - Tetyana Falalyeyeva
AU  - Pavlo Petakh
AU  - Iryna Halabitska
AU  - Oleksandr Kamyshnyi
AU  - Liubov Sichel
AU  - Nazarii Kobyliak
PY  - 2026
DA  - 2026/09/30
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706883
SN  - 1010-660X
SN  - 1648-9144
ER  -